Skip to main content

Advertisement

SpringerLink
Log in

Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease

  • REVIEW ARTICLE
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Remarkable regional differences in the annual incidence of endstage renal disease (ESRD) was found within Japan, which has a relatively homogeneous ethnic composition. In addition, there existed no regional difference in the incidence of ESRD due to polycystic kidney disease, the major genetic disorder of the kidneys. These findings suggest that the presence of factors other than genetic disposition contribute to the differences. On the other hand, there were similar regional variations in the incidences of ESRD between two causes of ESRD: chronic glomerulonephritis and diabetic nephropathy. Because it is unlikely that the regional distribution of underlying disease incidence and the disease-specific progression rate would be similar for two different causes, this observation suggests that factors governing the progression rate, which operate commonly for all causes of ESRD but differ among regions, may play an important role in generating the regional differences. Finally, we examined regional differences in the amounts of inhibitors of the renin-angiotensin system used, especially angiotensin-converting enzyme (ACE) inhibitors, in our search for an explanation of the regional differences in ESRD dynamics. Among antihypertensive agents examined, only ACE inhibitors were negatively correlated with the annual incidence of ESRD. The renal protective effects of ACE inhibitors have been established by results with animal models of progressive nephropathy and by large-scale clinical trials. Our epidemiological results for Japan as a whole show the same protective effects still more convincingly from a different approach. It is not completely clear yet at present, however, how regional variations in the incidence of ESRD are generated. If we could identify in future the factors that contribute to the regional differences, strategies for the treatment of renal disease will become available from different angles. Thus, much effort will be encouraged for the further analysis of regional differences in ESRD dynamics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413–46

    Google Scholar 

  2. InstitutionalAuthorNameUnited States Renal Data System (2003) USRDS 2003 Annual Data Report US Department of Health and Human Services Bethesda

    Google Scholar 

  3. InstitutionalAuthorNameJapanese Society Dialysis Therapy (2003) An overview of regular dialysis treatment in Japan (as of Dec. 31, 2001) JSDT Tokyo

    Google Scholar 

  4. T Usami K Koyama O Takeuchi K Morozumi G Kimura (2000) ArticleTitleRegional variations in the incidence of end-stage renal failure in Japan JAMA 284 2622–4 Occurrence Handle10.1001/jama.284.20.2622 Occurrence Handle1:STN:280:DC%2BD3M%2FktlGhsA%3D%3D Occurrence Handle11086370

    Article  CAS  PubMed  Google Scholar 

  5. T Usami R Sato A Yoshida G Kimura (2002) ArticleTitleRegional variation in end-stage renal disease Curr Opin Nephrol Hypertens 11 343–6 Occurrence Handle10.1097/00041552-200205000-00012 Occurrence Handle11981266

    Article  PubMed  Google Scholar 

  6. SJ Rosansky TL Huntsberger K Jackson P Eggers (1990) ArticleTitleComparative incidence rates of end-stage renal disease treatment by state Am J Nephrol 10 198–204 Occurrence Handle1:STN:280:By%2BA2c3nvVE%3D Occurrence Handle2382681

    CAS  PubMed  Google Scholar 

  7. B Foxman LH Moulton RA Wolfe KE Guire FK Port VM Hawthorne (1991) ArticleTitleGeographic variation in the incidence of treated end-stage renal disease J Am Soc Nephrol 2 1144–52 Occurrence Handle1:STN:280:By2C3srntVY%3D Occurrence Handle1777595

    CAS  PubMed  Google Scholar 

  8. A Cass J Cunningham Z Wang W Hoy (2001) ArticleTitleRegional variation in the incidence of end-stage renal disease in indigenous Australians Med J Aust 175 24–7 Occurrence Handle1:STN:280:DC%2BD3MvivV2lsw%3D%3D Occurrence Handle11476198

    CAS  PubMed  Google Scholar 

  9. AS Relman D Rennie (1980) ArticleTitleTreatment of end-stage renal disease: free but not equal N Engl J Med 303 996–8 Occurrence Handle1:STN:280:Bi6D3M7pvFc%3D Occurrence Handle7412853

    CAS  PubMed  Google Scholar 

  10. SG Rostand KA Kirk EA Rutsky BA Pate (1982) ArticleTitleRacial differences in the incidence of treatment for end-stage renal disease N Engl J Med 306 1276–9 Occurrence Handle1:STN:280:Bi2C2szgslU%3D Occurrence Handle7040967

    CAS  PubMed  Google Scholar 

  11. JC Whittle PK Whelton AJ Seidler MJ Klag (1991) ArticleTitleDoes racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med 151 1359–64 Occurrence Handle10.1001/archinte.151.7.1359 Occurrence Handle1:STN:280:By6B1M%2FpsF0%3D Occurrence Handle2064486

    Article  CAS  PubMed  Google Scholar 

  12. MJ Klag PK Whelton BL Randall JD Neaton FL Brancati J Stamler (1997) ArticleTitleEnd-stage renal disease in African-American and white men: 16-year MRFIT findings JAMA 277 1293–8 Occurrence Handle10.1001/jama.277.16.1293 Occurrence Handle1:STN:280:ByiB28zlsFY%3D Occurrence Handle9109467

    Article  CAS  PubMed  Google Scholar 

  13. JA Pugh MP Stern SM Haffner CW Eifler M Zapata (1988) ArticleTitleExcess incidence of treatment of end-stage renal disease in Mexican Americans Am J Epidemiol 127 135–44 Occurrence Handle1:STN:280:BieC3czkvVY%3D Occurrence Handle3276155

    CAS  PubMed  Google Scholar 

  14. HI Feldman MJ Klag AP Chiapella PK Whelton (1992) ArticleTitleEnd-stage renal disease in US minority groups Am J Kidney Dis 19 397–410 Occurrence Handle1:STN:280:By2B28vjsFM%3D Occurrence Handle1585925

    CAS  PubMed  Google Scholar 

  15. T Usami N Nakao M Fukuda O Takeuchi Y Kamiya A Yoshida et al. (2003) ArticleTitleMaps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan Kidney Int 64 1445–9 Occurrence Handle10.1046/j.1523-1755.2003.00221.x Occurrence Handle12969164

    Article  PubMed  Google Scholar 

  16. N Kato T Usami M Fukuda M Motokawa Y Kamiya A Yoshida et al. (2005) ArticleTitleDifferent regional dynamics of end-stage renal disease in Japan by different causes Nephrology 10 400–4 Occurrence Handle10.1111/j.1440-1797.2005.00404.x Occurrence Handle16109089

    Article  PubMed  Google Scholar 

  17. M Zeier P Fehrenbach S Geberth K Mohring R Waldherr E Ritz (1992) ArticleTitleRenal histology in polycystic kidney disease with incipient and advanced renal failure Kidney Int 42 1259–65 Occurrence Handle1:STN:280:ByyD1crptl0%3D Occurrence Handle1453612

    CAS  PubMed  Google Scholar 

  18. TM Kennefick MA Al-Nimri TT Oyama MM Thompson FJ Kelly JG Chapman et al. (1999) ArticleTitleHypertension and renal injury in experimental polycystic kidney disease Kidney Int 56 2181–90 Occurrence Handle10.1046/j.1523-1755.1999.00783.x Occurrence Handle1:CAS:528:DC%2BD3cXisVChtg%3D%3D Occurrence Handle10594794

    Article  CAS  PubMed  Google Scholar 

  19. AB Chapman AM Johnson PA Gabow RW Schrier (1994) ArticleTitleOvert proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease J Am Soc Nephrol 5 1349–54 Occurrence Handle1:STN:280:ByqB3c7it10%3D Occurrence Handle7894001

    CAS  PubMed  Google Scholar 

  20. G Maschio D Alberti G Janin F Locatelli JF Mann M Motolese et al. (1996) ArticleTitleEffect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group N Engl J Med 334 939–45 Occurrence Handle10.1056/NEJM199604113341502 Occurrence Handle1:CAS:528:DyaK28XislKmsbg%3D Occurrence Handle8596594

    Article  CAS  PubMed  Google Scholar 

  21. MA van Dijk MH Breuning R Duiser LA Van Es RG Westendorp (2003) ArticleTitleNo effect of enalapril on progression in autosomal dominant polycystic kidney disease Nephrol Dial Transplant 18 2314–20 Occurrence Handle1:CAS:528:DC%2BD3sXot1Gjt7g%3D Occurrence Handle14551359

    CAS  PubMed  Google Scholar 

  22. R Schrier K McFann A Johnson A Chapman C Edelstein G Brosnahan et al. (2002) ArticleTitleCardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a 7-year prospective randomized study J Am Soc Nephrol 13 1733–9 Occurrence Handle10.1097/01.ASN.0000018407.60002.B9 Occurrence Handle12089368

    Article  PubMed  Google Scholar 

  23. S Klahr JA Breyer GJ Beck VW Dennis JA Hartman D Roth et al. (1995) ArticleTitleDietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group J Am Soc Nephrol 5 2037–47 Occurrence Handle1:STN:280:BymD2szitFU%3D Occurrence Handle7579052

    CAS  PubMed  Google Scholar 

  24. T Ecder AB Chapman GM Brosnahan CL Edelstein AM Johnson RW Schrier (2002) ArticleTitleEffect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease Am J Kidney Dis 35 427–32

    Google Scholar 

  25. JB Rosman K Langer M Brandl TP Piers-Becht GK Van der Hem PM Ter Wee et al. (1989) ArticleTitleProtein-restricted diets in chronic renal failure: a 4-year follow-up shows limited indications Kidney Int 27 IssueIDSuppl S96–S102 Occurrence Handle1:STN:280:By%2BB28rgslw%3D

    CAS  Google Scholar 

  26. TH Jafar PC Stark CH Schmid S Strandgaard A-L Kamper G Maschio et al. (2005) ArticleTitleThe effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease Kidney Int 67 265–71 Occurrence Handle10.1111/j.1523-1755.2005.00077.x Occurrence Handle1:CAS:528:DC%2BD2MXotFKnsQ%3D%3D Occurrence Handle15610250

    Article  CAS  PubMed  Google Scholar 

  27. T Ecder CL Edelstein GM Fick-Brosnahan AM Johnson AB Chapman PA Gabow et al. (2001) ArticleTitleDiuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease Am J Nephrol 21 98–103 Occurrence Handle10.1159/000046231 Occurrence Handle1:STN:280:DC%2BD3M3mslKisQ%3D%3D Occurrence Handle11359016

    Article  CAS  PubMed  Google Scholar 

  28. CY Hsu F Lin E Vittinghoff MG Shlipak (2003) ArticleTitleRacial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States J Am Soc Nephrol 14 2902–7 Occurrence Handle10.1097/01.ASN.0000091586.46532.B4 Occurrence Handle14569100

    Article  PubMed  Google Scholar 

  29. R Zatz BR Dunn TW Meyer S Anderson HG Rennke BM Brenner (1986) ArticleTitlePrevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension J Clin Invest 77 1925–30 Occurrence Handle1:CAS:528:DyaL28XktFyit7s%3D Occurrence Handle3011862

    CAS  PubMed  Google Scholar 

  30. S Anderson HG Rennke BM Brenner (1986) ArticleTitleTherapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat J Clin Invest 77 1993–2000 Occurrence Handle1:CAS:528:DyaL28XktFyit7g%3D Occurrence Handle3011863

    CAS  PubMed  Google Scholar 

  31. EJ Lewis LG Hunsicker RP Bain RD Rohde InstitutionalAuthorNamefor The Collaborative Study Group (1993) ArticleTitleThe effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1456–62 Occurrence Handle1:STN:280:ByuD3MbmtFM%3D Occurrence Handle8413456

    CAS  PubMed  Google Scholar 

  32. BM Brenner EV Lawler HS Mackenzie (1996) ArticleTitleThe hyperfiltration theory: a paradigm shift in nephrology Kidney Int 49 1774–7 Occurrence Handle1:STN:280:BymA3snlvFM%3D Occurrence Handle8743495

    CAS  PubMed  Google Scholar 

  33. LY Agodoa L Appel GL Bakris G Beck J Bourgoignie JP Briggs et al. (2001) ArticleTitleEffect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial JAMA 285 2719–28 Occurrence Handle10.1001/jama.285.21.2719 Occurrence Handle1:STN:280:DC%2BD3MzltVChtQ%3D%3D Occurrence Handle11386927

    Article  CAS  PubMed  Google Scholar 

  34. JT Wright SuffixJr G Bakris T Greene LY Agodoa LJ Appel J Charleston et al. (2002) ArticleTitleEffect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial JAMA 288 2421–31 Occurrence Handle1:CAS:528:DC%2BD38XoslOktr8%3D Occurrence Handle12435255

    CAS  PubMed  Google Scholar 

  35. G Contreras T Greene LY Agodoa D Cheek G Junco D Dowie et al. (2005) ArticleTitleBlood pressure control, drug therapy, and kidney disease Hypertension 46 44–50 Occurrence Handle10.1161/01.HYP.0000166746.04472.60 Occurrence Handle1:CAS:528:DC%2BD2MXlt1Wltrg%3D Occurrence Handle15897360

    Article  CAS  PubMed  Google Scholar 

  36. P Ruggenenti A Fassi AP Ilieva S Bruno IP Iliev V Brusegan et al. (2004) ArticleTitlePreventing microalbuminuria in type 2 diabetes N Engl J Med 351 1941–51 Occurrence Handle10.1056/NEJMoa042167 Occurrence Handle1:CAS:528:DC%2BD2cXps1Wlt70%3D Occurrence Handle15516697

    Article  CAS  PubMed  Google Scholar 

  37. M Tonelli L Moye FM Sacks T Cole GC Curhan (2003) ArticleTitleEffect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease J Am Soc Nephrol 14 1605–13 Occurrence Handle1:CAS:528:DC%2BD3sXjslantbc%3D Occurrence Handle12761262

    CAS  PubMed  Google Scholar 

  38. M Epstein VM Campese (2005) ArticleTitlePleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on renal function Am J Kidney Dis 45 2–14 Occurrence Handle10.1053/j.ajkd.2004.08.040 Occurrence Handle1:CAS:528:DC%2BD2MXhtVOrsbk%3D Occurrence Handle15696439

    Article  CAS  PubMed  Google Scholar 

  39. T Usami N Nakao M Fukuda A Yoshida G Kimura (2004) ArticleTitleRenoprotective action of statin estimated from mapping renal failure in Japan Kidney Int 65 1520 Occurrence Handle10.1111/j.1523-1755.2004.555_3.x Occurrence Handle15086499

    Article  PubMed  Google Scholar 

  40. BM Brenner TW Meyer TH Hostetter (1982) ArticleTitleDietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease N Engl J Med 307 652–9 Occurrence Handle1:STN:280:Bi2B2s3hsVw%3D Occurrence Handle7050706

    CAS  PubMed  Google Scholar 

  41. R Zatz TW Meyer HG Rennke BM Brenner (1985) ArticleTitlePredominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy Proc Natl Acad Sci USA 82 5963–7 Occurrence Handle1:CAS:528:DyaL2MXlsFyntbY%3D Occurrence Handle3862110

    CAS  PubMed  Google Scholar 

  42. K Zeller E Whittaker L Sullivan P Raskin HR Jacobson (1991) ArticleTitleEffect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus N Engl J Med 324 78–84 Occurrence Handle1:STN:280:By6D2svitlA%3D Occurrence Handle1984187

    CAS  PubMed  Google Scholar 

  43. JD Walker JJ Bending RA Dodds MB Mattock TJ Murrells H Keen et al. (1989) ArticleTitleRestriction of dietary protein and progression of renal failure in diabetic nephropathy Lancet II 1411–5

    Google Scholar 

  44. BU Ihle GJ Becker JA Whitworth RA Charlwood PS Kincaid-Smith (1989) ArticleTitleThe effect of protein restriction on the progression of renal insufficiency N Engl J Med 321 1773–7 Occurrence Handle1:STN:280:By%2BD1c7nslE%3D Occurrence Handle2512486

    CAS  PubMed  Google Scholar 

  45. F Locatelli D Alberti G Graziani G Buccianti B Redaelli A Giangrande (1991) ArticleTitleProspective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group Lancet 337 1299–304 Occurrence Handle10.1016/0140-6736(91)92977-A Occurrence Handle1:STN:280:By6B3s3ivVw%3D Occurrence Handle1674294

    Article  CAS  PubMed  Google Scholar 

  46. S Klahr AS Levery GJ Beck AW Caggiula L Hunsicker JW Kusek et al. (1994) ArticleTitleThe effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group N Engl J Med 330 877–84 Occurrence Handle10.1056/NEJM199403313301301 Occurrence Handle1:STN:280:ByuC2MbgtFQ%3D Occurrence Handle8114857

    Article  CAS  PubMed  Google Scholar 

  47. MT Pedrini AS Levey J Lau TC Chalmers PH Wang (1996) ArticleTitleThe effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis Ann Intern Med 124 627–32 Occurrence Handle1:STN:280:BymB3c7itlE%3D Occurrence Handle8607590

    CAS  PubMed  Google Scholar 

  48. BL Kasiske JD Lakatua JZ Ma TA Louis (1998) ArticleTitleA meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function Am J Kidney Dis 31 954–61 Occurrence Handle1:CAS:528:DyaK1cXktVSjsLo%3D Occurrence Handle9631839

    CAS  PubMed  Google Scholar 

  49. WE Mitch (1991) ArticleTitleDietary protein restriction in chronic renal failure: nutritional efficacy, compliance, and progression of renal insufficiency J Am Soc Nephrol 2 823–31 Occurrence Handle1:STN:280:By2D1cbltlU%3D Occurrence Handle1751785

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Pathophysiology, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya, 467-8601, Japan

    Takeshi Usami & Genjiro Kimura

Authors
  1. Takeshi Usami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Genjiro Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takeshi Usami.

Additional information

This article was presented as the Oshima Award memorial lecture at the 48th annual meeting of the Japanese Society of Nephrology, held at Yokohama, Japan, on June 24, 2005.

About this article

Cite this article

Usami, T., Kimura, G. Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease. Clin Exp Nephrol 10, 8–12 (2006). https://doi.org/10.1007/s10157-005-0404-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-005-0404-5

Key words

Search

Navigation